سعر مبروسين ساجا 2% مرهم 15 جم 2022

Mupirocin Saja 2% top. oint. 15 gm (Saja Pharma): mupirocin 2% topical antibacterial ointment, 15 g tube.

• Topical treatment of impetigo due to susceptible Staphylococcus aureus and Streptococcus pyogenes.DailyMed (U.S. National Library of Medicine)
• Skin infections, e.g. impetigo, folliculitis and furunculosis.electronic medicines compendium (emc), MHRA-authorised

• In clinical trials: burning, stinging or pain (1.5%) and itching (1%); rash, nausea, erythema, dry skin, tenderness, swelling, contact dermatitis and increased exudate in less than 1%.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Common: burning localised to the application site. Uncommon: itching, erythema, stinging and dryness at the site; cutaneous sensitisation. Very rare: systemic allergic reactions.International label, equivalent formulation · electronic medicines compendium (emc), MHRA-authorised

• Known hypersensitivity to mupirocin or any excipient of the ointment.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity to the active substance or to any of the excipients.International label, equivalent formulation · electronic medicines compendium (emc), MHRA-authorised

• Severe allergic reactions (anaphylaxis, urticaria, angioedema, generalised rash) have been reported.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Avoid contact with eyes; discontinue in case of sensitisation or severe local irritation; prolonged use may cause overgrowth of non-susceptible organisms including fungi.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Clostridioides difficile-associated diarrhoea has been reported with nearly all antibacterials; evaluate if diarrhoea occurs.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Insufficient human data to establish a drug-associated risk; systemic absorption through intact skin is minimal; no developmental toxicity in rats or rabbits.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• No clinical experience in pregnancy; animal studies showed no harm to the foetus; use in pregnancy only when potential benefits outweigh possible risks.International label, equivalent formulation · electronic medicines compendium (emc), MHRA-authorised
• Breastfeeding is not expected to expose the child because of minimal systemic absorption; a treated breast or nipple should be thoroughly washed before breastfeeding.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Mupirocin: Reversibly inhibits bacterial isoleucyl-tRNA synthetase, arresting protein synthesis; minimal systemic absorption, rapidly metabolised to inactive monic acid.